Starkey Evolv AI vs Vivtone Xpure Hearing Aid
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Starkey Evolv AI
The Starkey Evolv AI is a premium prescription behind-the-ear hearing aid released in 2022, currently available at $4,598. In HearAdvisor's lab testing, it earns a B grade with a SoundScore of 3.9/5, ranking #30 of 39 prescription hearing aids tested. This device shows notable strengths in specific performance areas. Music streaming quality scores a solid 3.7/5, which is +0.94 points above the category average—a meaningful advantage for users who frequently stream audio from their phone. Speech in noise performance also stands out at 2.8/5, sitting +0.66 points above the category average, though this remains a mixed absolute score. Speech in quiet is solid at 3.4/5, essentially matching the category average. The Evolv AI does show some limitations in our testing. Own voice comfort scores 2.1/5, falling -0.60 points below the category average, which may affect how natural your own speech sounds. Feedback handling presents a more significant gap: while the 3.5/5 score is solid in absolute terms, it sits -1.22 points below the category average of 4.72/5, meaning competing prescription devices generally perform better in feedback stability tests. Professional fitting makes a meaningful difference with this device. The normalized Initial Score of 3.8/5 improves to 4.2/5 after tuning, a +0.4 point gain primarily driven by improvements in speech clarity metrics. At this premium price point, several competitors like the Phonak Sphere Infinio and Oticon Intent deliver higher overall scores. The Evolv AI is best suited for users who prioritize music streaming quality and speech understanding in noise, and who have access to professional fitting services to optimize performance.

Vivtone Xpure Hearing Aid
The Vivtone Xpure is a behind-the-ear OTC hearing aid priced at $549, earning a B grade with a SoundScore of 3.1/5 in HearAdvisor's lab testing. This places it in the lower tier of the OTC category, ranking #57 of 65 devices tested. The Xpure demonstrates a notably uneven performance profile. Its standout strength is music streaming, scoring an excellent 4.4/5—a remarkable 2.48 points above the category average. This makes it one of the better choices for users who prioritize audio entertainment through their hearing aids. Speech in quiet performs just slightly above category average at 2.9/5, though this remains mixed in absolute terms. However, the device shows significant weaknesses in several areas. Own-voice comfort scores a low 0.8/5, falling 1.71 points below the category average—a notable concern for users sensitive to how their own voice sounds. Speech in noise at 1.2/5 sits below the category average, and feedback handling, while solid at 3.3/5, still falls 1.24 points below what typical OTC devices achieve. The Xpure improves meaningfully with professional tuning, jumping from a normalized Initial Score of 3.0/5 to a Tuned Score of 3.5/5. Shoppers prioritizing music streaming may find value here, but those seeking balanced speech performance or natural own-voice quality should consider alternatives like the Linner Nova Earbud or Nuheara IQBuds Max, which offer higher overall scores at lower prices.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit